Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

被引:160
作者
Durbin, Anna P. [2 ]
Vargas, Maria Jose [3 ]
Wanionek, Kimberli [2 ]
Hammond, Samantha N. [4 ]
Gordon, Aubree [1 ]
Rocha, Crisanta [5 ]
Balmaseda, Angel [3 ]
Harris, Eva [1 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[3] Minist Hlth, Ctr Nacl Diagnost & Referencia, Dept Virol, Managua, Nicaragua
[4] Ctr Salud Socrates Flores Vivas, Sustainable Sci Inst, Managua, Nicaragua
[5] Hosp Infantil Manuel del Jesus Rivera, Managua, Nicaragua
关键词
dengue; immunopathogenesis; activated monocytes; PBMCs; infection; replication; Nicaragua;
D O I
10.1016/j.virol.2008.03.028
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In vitro studies have attempted to identify dengue Virus (DEN) target cells in peripheral blood; however, extensive phenotyping of peripheral blood mononuclear cells (PBMCs) from dengue patients has not been reported. PBMCs collected from hospitalized children suspected of acute dengue were analyzed for DEN prM, CD32, CD86, CD14, CD11c, CD16, CD209, CCR7, CD4, and CD8 by flow cytometry to detect DEN antigen in PBMCs and to phenotype DEN-positive cells. DEN prM was detected primarily in activated monocytes (CD14(+), CD32(+), CD86(+), CD11c(+)). A subset of samples analyzed for DEN nonstructura) protein 3 (NS3) confirmed that approximately half of DEN antigen-positive cells contained replicating virus. A higher percentage of PBMCs from DHF patients expressed prM, CD86, CD32, and CD11c than did those from DF patients. Increased activation of monocytes and greater numbers of DEN-infected cells were associated with more severe dengue, implicating a role for monocyte activation in dengue immunopathogenesis. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:429 / 435
页数:7
相关论文
共 57 条
  • [1] [Anonymous], 2001, FLAVIVIRUSES FIELDS
  • [2] Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x
  • [3] Characterisation of lymphocyte response and cytokine patterns in patients with Dengue fever
    Azeredo, EL
    Zagne, SMO
    Santiago, MA
    Gouvea, AS
    Santana, AA
    Neves-Souza, PCF
    Nogueira, RMR
    Miagostovich, MP
    Kubelka, CF
    [J]. IMMUNOBIOLOGY, 2001, 204 (04) : 494 - 507
  • [4] High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua
    Balmaseda, Angel
    Hammond, Samantha N.
    Tellez, Yolanda
    Imhoff, Laurel
    Rodriguez, Yoryelin
    Saborio, Saira I.
    Mercado, Juan C.
    Perez, Leonel
    Videa, Elsa
    Almanza, Elvis
    Kuan, Guillermina
    Reyes, Miguel
    Saenz, Leyla
    Amador, Juan J.
    Harris, Eva
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2006, 11 (06) : 935 - 942
  • [5] Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever
    Bethell, DB
    Flobbe, K
    Phuong, CXT
    Day, NPJ
    Phuong, PT
    Buurman, WA
    Cardosa, MJ
    White, NJ
    Kwiatkowski, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) : 778 - 782
  • [6] B7-1 and B7-2: Similar costimulatory ligands with different biochemical, oligomeric and signaling properties
    Bhatia, S
    Edidin, M
    Almo, SC
    Nathenson, SG
    [J]. IMMUNOLOGY LETTERS, 2006, 104 (1-2) : 70 - 75
  • [7] A PROSPECTIVE-STUDY OF DENGUE INFECTIONS IN BANGKOK
    BURKE, DS
    NISALAK, A
    JOHNSON, DE
    SCOTT, RM
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1988, 38 (01) : 172 - 180
  • [8] Chaturvedi UC, 1999, J MED VIROL, V59, P335, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt
  • [9] 335::AID-JMV13&gt
  • [10] 3.0.CO